+
Site Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

Related Videos

LAAO Summit - Decoding DRT patient factors

LAAO Summit - Imaging debate: ICE

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit - LAAO with risk of leak

LAAO Summit - LAAO in a patient at risk of DRT

LAA patient video: Maria

LAAO Summit - Mastering leaks

LAAO Summit - Ideal vs suboptimal LAAO implant

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Amulet™ LAA Occluder

The Amulet IDE Trial

Monitoring for AF prior to PFO closure

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - LAAO in a patient at risk of DRT

LAAO Summit - Sealing the appendage

LAAO Summit - Device placement and DRT

LAAO Summit - LAA anatomy focusing

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline